Statistics

Total Visits

Views
Response-adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first-line immunochemotherapy: Results of the RBMDGELTAMO08 phase II trial87

File Visits

Downloads
7415-31389.pdf32

Select a period of time:

Number of views in the range

Views
Response-adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first-line immunochemotherapy: Results of the RBMDGELTAMO08 phase II trial39

Number of downloads in the range

Downloads
7415-31389.pdf10

Views

Views
July 202516
August 20251
September 20256
October 20252
November 20254
December 20250
January 202610
Download CSV file
 untranslated
 untranslated

Number of downloads in the period of time

  • Downloads
  • July 2025
    0
  • August 2025
    0
  • September 2025
    1
  • October 2025
    0
  • November 2025
    4
  • December 2025
    5
  • January 2026
    0
  • Download CSV file
 untranslated
 untranslated

Top country views

Views
United States15
Brazil12
Germany2
Chile2
Canada1
Ecuador1
Finland1
United Kingdom1
Morocco1
Tunisia1
 

Top countries by downloads

Downloads
United States5
Finland1
United Kingdom1
 

Top cities views

Views
San Jose10
Rio de Janeiro2
Aachen1
Ariquemes1
Averill Park1
Cafelândia1
Camaragibe1
Dallas1
Garibaldi1
Guayaquil1
 

Top cities by downloads

Downloads